Skip to main content
Clinical Trials/CTRI/2026/04/108179
CTRI/2026/04/108179
Not yet recruiting
Not Applicable

To Evaluate the Efficacy of Bone Marrow Derived Mononuclear Stem Cells Combined with Platelet Rich Plasma Seeded into Allogenic Bone Graft in Alveolar Bone Grafting in cleft patients – A Novel Revolutionary Technique

Not provided0 sites30 target enrollmentStarted: April 30, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30

Overview

Brief Summary

The aim of this study is to assess the bone regenerative ability of autologous bone marrow derived mononuclear stem cells in combination with Platelet Rich Plasma seeded into allogenic bone graft in Alveolar bone grafting HYPOTHESIS - Autologous Bonoemarrow mononuclear stem cells in combination with platelet rich plasma seeded into Allogenic bone graft acts as osteogenic graft in promoting superior bone regeneration in alveolar bone grafting and this technique can be considered as an alternative for iliac bone harvesting

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
5.00 Year(s) to 15.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients born with alveolar defects including cleft lip and palate Patients age range 5-15years Non syndromic patients Non infectious patients Patients willing to be part of the study.

Exclusion Criteria

  • Patients who underwent previous SABG procedure Syndromic patient Patients with uncontrolled systemic diseases Immunocompromised or immune suppressed patients Patients with Cardiac abnormalities Hematologic diseases Paget’s disease Osteopetrosis Rickets Any other Bony pathological conditions neoplastic condition Chemotherapy.

Investigators

Sponsor
Not provided
Responsible Party
Principal Investigator
Principal Investigator

Acchuthaubanyashri

Meenakshi Ammal Dental College And Hospital

Similar Trials